Tower Research Capital LLC (Trc) Ac Immune Sa Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Ac Immune Sa stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,074 shares of ACIU stock, worth $11,373. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,074

Previous 5,830 47.27%

Holding current value

$11,373

Previous $17,000 29.41%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$2.29 - $4.87 $6,311 - $13,421	-2,756 Reduced 47.27%	3,074 $12,000
Q1 2024 May 15, 2024	BUY	$2.66 - $4.87 $13,438 - $24,603	5,052 Added 649.36%	5,830 $17,000
Q4 2023 Feb 13, 2024	SELL	$2.46 - $5.0 $46,395 - $94,300	-18,860 Reduced 96.04%	778 $3,000
Q3 2023 Nov 14, 2023	BUY	$2.77 - $3.38 $53,316 - $65,058	19,248 Added 4935.38%	19,638 $55,000
Q2 2023 Aug 14, 2023	SELL	$1.85 - $3.4 $301 - $554	-163 Reduced 29.48%	390 $1,000
Q1 2023 May 09, 2023	BUY	$2.13 - $2.49 $1,177 - $1,376	553 New	553 $1,000
Q3 2022 Nov 10, 2022	BUY	$2.4 - $3.64 $2,212 - $3,356	922 Added 38.23%	3,334 $11,000
Q2 2022 Aug 15, 2022	SELL	$2.35 - $4.47 $12,325 - $23,445	-5,245 Reduced 68.5%	2,412 $9,000
Q1 2022 May 12, 2022	BUY	$3.5 - $5.16 $7,581 - $11,176	2,166 Added 39.45%	7,657 $30,000
Q4 2021 Feb 14, 2022	SELL	$4.83 - $7.56 $27,531 - $43,092	-5,700 Reduced 50.93%	5,491 $28,000
Q3 2021 Nov 15, 2021	BUY	$6.2 - $8.34 $55,626 - $74,826	8,972 Added 404.33%	11,191 $75,000
Q2 2021 Aug 16, 2021	SELL	$6.04 - $8.37 $16,724 - $23,176	-2,769 Reduced 55.51%	2,219 $18,000
Q1 2021 May 17, 2021	SELL	$5.32 - $8.96 $8,708 - $14,667	-1,637 Reduced 24.71%	4,988 $38,000
Q4 2020 Feb 16, 2021	SELL	$4.47 - $5.58 $728 - $909	-163 Reduced 2.4%	6,625 $34,000
Q3 2020 Nov 16, 2020	BUY	$4.78 - $9.06 $66 - $126	14 Added 0.21%	6,788 $33,000
Q2 2020 Aug 13, 2020	BUY	$6.57 - $8.3 $44,426 - $56,124	6,762 Added 56350.0%	6,774 $45,000
Q1 2020 May 15, 2020	SELL	$4.24 - $9.89 $37,006 - $86,319	-8,728 Reduced 99.86%	12 $0
Q4 2019 Feb 07, 2020	SELL	$4.56 - $8.78 $16,935 - $32,608	-3,714 Reduced 29.82%	8,740 $75,000
Q3 2019 Nov 05, 2019	BUY	$4.8 - $5.89 $59,779 - $73,354	12,454 New	12,454 $62,000
Q2 2019 Aug 13, 2019	SELL	$4.72 - $5.88 $38,534 - $48,004	-8,164 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$3.65 - $11.68 $29,798 - $95,355	8,164 New	8,164 $41,000
Q4 2018 Feb 14, 2019	SELL	$7.35 - $11.7 $29,532 - $47,010	-4,018 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$7.88 - $16.45 $31,661 - $66,096	4,018 New	4,018 $32,000
Q1 2018 May 15, 2018	SELL	$10.34 - $13.78 $5,676 - $7,565	-549 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$10.37 - $12.85 $5,693 - $7,054	549	549 $7,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

28.6M

Call Options Held

163K

Put Options Held

37.6K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $309M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Ac Immune Sa Transaction History